Imiquimod NDC 51672-4174

NDC codes

FDA NDC Directory

Product NDC (as listed)51672-4174Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51672-4174Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51672-4174-6	51672417406	28 PACKET in 1 CARTON (51672-4174-6) / .25 g in 1 PACKET (51672-4174-8)Marketed from Jan 26, 2021
51672-4174-9	51672417409	1 BOTTLE, PUMP in 1 CARTON (51672-4174-9) / 7.5 g in 1 BOTTLE, PUMPMarketed from Oct 14, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Imiquimod
Generic name (nonproprietary): imiquimod
Active ingredients: Imiquimod — 37.5 mg/g
Dosage form: Cream
Route: Topical
Labeler: Sun Pharmaceutical Industries, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205971
Marketing start: Jan 26, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Increased Cytokine Activity (Physiologic effect)Increased Cytokine Production (Physiologic effect)Interferon Inducers (Mechanism)
Identifiers: Product ID 51672-4174_48e9d045-e9a2-8452-e063-6294a90af1e9SPL ID 48e9d045-e9a2-8452-e063-6294a90af1e9SPL set ID 51913a5a-1cab-4b9e-b2c2-e0174062df73RxCUI 967017UNII P1QW714R7MUPC 0351672417499

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451672417406 followed by a unit qualifier and the quantity

Package 51672-4174-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 21, 2026.

Indications (excerpt from the label)

Imiquimod cream, 3.75% is indicated for the topical treatment of clinically typical, visible, or palpable actinic keratoses (AK) of the face or balding scalp in immunocompetent adults. (1.1) • Imiquimod cream, 3.75% is indicated for the topical treatment of external genital and perianal warts (EGW) in immunocompetent patients 12 years of age or older. (1.2) 1.1 Actinic Keratosis Imiquimod cream, 3.75% is indicated for the topical treatment of clinically typical, visible or palpable actinic keratoses (AK) of the face or balding scalp in immunocompetent adults. 1.2 External Genital Warts Imiquimod cream, 3.75% is indicated for the topical treatment of external genital and perianal warts (EGW) …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)